Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Kanjia, Megha K. [VerfasserIn]   i
 Jooste, Edmund H. [VerfasserIn]   i
 Illig, Melissa [VerfasserIn]   i
 Neifeld Capps, Jennifer [VerfasserIn]   i
 Eisner, Christoph [VerfasserIn]   i
 Fan, Shou Zen [VerfasserIn]   i
 Lenarczyk, Jerzy [VerfasserIn]   i
 Wojdacz, Rafał [VerfasserIn]   i
Titel:Optimizing the anesthetic care of patients with aromatic l-amino acid decarboxylase deficiency
Verf.angabe:Megha K. Kanjia, Edmund H. Jooste, Melissa Illig, Jennifer Neifeld Capps, Christoph Eisner, Shou Zen Fan, Jerzy Lenarczyk, Rafał Wojdacz
E-Jahr:2025
Jahr:February 2025
Umfang:8 S.
Illustrationen:Illustrationen
Fussnoten:Online veröffentlicht: 22 October 2024 ; Gesehen am 11.04.2025
Titel Quelle:Enthalten in: Pediatric anesthesia
Ort Quelle:Oxford [u.a.] : Wiley-Blackwell, 1991
Jahr Quelle:2025
Band/Heft Quelle:35(2025), 2 vom: Feb., Seite 99-106
ISSN Quelle:1460-9592
Abstract:Aromatic l-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive disorder that results in a lack of the monoamine neurotransmitters dopamine, serotonin, norepinephrine, and epinephrine. Patients present with a wide spectrum of symptoms, including motor and autonomic dysfunction, hypotonia, and developmental delay, often before the age of one. Until recently, treatment options were limited to symptom control, but the recent approval of the first gene therapy for AADC deficiency in Europe and the UK has provided an alternative to treating symptoms for this disease. Eladocagene exuparvovec is a one-time gene therapy, administered bilaterally to the putamen by magnetic resonance imaging-guided stereotactic neurosurgery. While administration of the gene therapy itself is minimally invasive, the anesthetic management of patients with AADC deficiency is challenging due to the absence of sympathetic regulation secondary to the lack of adrenergic neurotransmitters. Optimal anesthetic management requires an understanding of the complex and heterogeneous nature of the disease. Hemodynamic instability, temperature dysregulation, and hypoglycemia are of primary concern, but there are also challenges regarding intravenous access and airway management. A thorough preoperative assessment is essential and should be guided by the patient's history. Advanced planning is necessary regarding the timing of the procedure schedule and operative plan; meticulous preparation, simulation for the operating room, as well as communication with all perioperative staff members, are crucial. Intraoperatively, utmost care must be taken to protect the skin, maintain body temperature, and to prepare for inotropic and/or glycemic support as needed. Postoperative intensive care management is necessary for consideration of postoperative extubation and provision of supportive care. With careful planning, preparation, and vigilance, patients with AADC deficiency can safely undergo anesthesia.
DOI:doi:10.1111/pan.15025
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1111/pan.15025
 kostenfrei: Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/pan.15025
 DOI: https://doi.org/10.1111/pan.15025
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:AADC deficiency
 anesthesia
 gene therapy
 perioperative management
K10plus-PPN:1922506648
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69330414   QR-Code
zum Seitenanfang